by Eamonn | Jul 16, 2021 | News
On its 10th anniversary, University of Oxford’s ISARIC (International Severe Acute Respiratory and Emerging Infection Consortium) demonstrates the crucial role of global preparedness and collaboration for advancing knowledge on infectious disease pandemics. COVID-19...
by Eamonn | Jul 14, 2021 | News
Researchers from ISARIC (International Severe Acute Respiratory and emerging Infection Consortium) paediatric Long Covid working group in the UK, Sechenov University and Z.A. Bashlyaeva Children’s Municipal Clinical Hospital in Russia ran the largest study to date on...
by Eamonn | Jul 8, 2021 | News
Ribavirin is the only available Lassa fever–specific treatment and has been used routinely for over 25 years. However, Ribavirin is not licensed for Lassa fever, its mechanism of action is unclear, it’s expensive and hard to source, and it has well-known...
by Eamonn | Mar 24, 2021 | News
Women under 50 and people who experienced severe disease had worse long-term outcomes following hospitalisation with COVID-19. The first long-term follow-up data from the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) Clinical...
by Eamonn | Mar 10, 2021 | News
In the largest study of its kind to date, the UK’s International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), supported by the UK Coronavirus Immunology Consortium (UK-CIC), has identified new biomarkers of inflammation that both indicate the...
by Eamonn | Feb 15, 2021 | News, Uncategorised
The Lancet Infectious Diseases published the GloPID-R and ISARIC Long COVID Forum Working Group’ letter, describing the content and discussions of the Long COVID Forum which took place on 9-10 December 2020. This global public forum, organised by ISARIC, GloPID-R and...
